Oncology Small Molecule Drugs Market
Oncology Small Molecule Drugs Market Analysis, By Drug Class (Chemotherapy Drugs, Immunomodulating Drugs, Targeted Therapy Drugs, and Hormonal Therapy), By Indication, By Route of Administration (Oral, and Injectable), By Distribution Channel, and Region - Market Insights 2025 to 2035
According to Fact.MR estimates, the Oncology Small Molecule Drugs market stood at USD 94,494 million in 2025. The market is projected to reach USD 100,069 million in 2026 and climb to USD 177,430 million by 2036, progressing at a CAGR of 5.9%. Targeted therapy drugs are anticipated to account for a leading share of 44% drug class segment, while hospital pharmacies are expected to remain the dominant distribution channel segment with around 38.2% share, driven by advancements in targeted therapy, rising prevalence of cancer globally
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT3747MR
- 28 Feb 2025
- Healthcare
- 170 Pages
- Tables
- Figures
- Base Value(2024): 89230 Mn
- Estimated Value(2026): 100069 Mn
- Forecast Value (2036): 177430 Mn
- CAGR (2026 - 2036): 5.9%
Table of Content
- Executive Summary
- Industry Introduction, including Taxonomy and Market Definition
- Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- By Drug Class
- By Route of Administration
- By Indication
- By Distribution Channel
- By Drug Class
- Chemotherapy Drugs
- Alkylating Agents
- Antimetabolites
- Other Drugs
- Immunomodulating Drugs
- Targeted Therapy Drugs
- Proteasome Inhibitors
- Tyrosine Kinase Inhibitors
- mTOR Inhibitors
- Others
- Hormonal Therapy
- Chemotherapy Drugs
- By Route of Administration
- Oral
- Injectable
- By Indication
- NSCLC
- Renal Cell Carcinoma
- Breast Cancer
- Prostate Cancer
- Multiple Myeloma
- Melanoma
- Lymphoma
- Leukemia
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Clinics
- Online Pharmacies
- By Region
- Sales Forecast to 2035 by Drug Class, Route of Administration, Indication, and Distribution Channel for 30 Countries
- Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
- Company Profile
- AstraZeneca
- 4SC AG
- Immunocure Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Gilead Sciences Inc.
- GlaxoSmithKline PLC
- Merck KGaA
- Hoffmann-La Roche Ltd
- Accent Therapeutics
Oncology Small Molecule Drugs Market